Ardelyx Inc
Change company Symbol lookup
Select an option...
ARDX Ardelyx Inc
SNN Smith & Nephew PLC
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
HNFSA Hanover Foods Corp
HJLI Hancock Jaffe Laboratories Inc
HHSE Hannover House Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical products segment. The Company's products line includes cardiorenal portfolio and gastrointestinal portfolio. The Company's cardiorenal portfolio includes two Phase III clinical product candidates, tenapanor in Phase III clinical development for treating hyperphosphatemia in end-stage renal disease (ESRD) patients on dialysis and RDX7675 in Phase III clinical development for treating hyperkalemia in chronic kidney disease (CKD) and heart failure patients. The cardiorenal portfolio includes tenapanor, RDX7675, RDX013 and RDX011. Its gastrointestinal portfolio is led by tenapanor for the treatment of irritable bowel syndrome with constipation (IBS-C). The gastrointestinal portfolio includes tenapanor, RDX8940, RDX011 and RDX023.

Closing Price
$6.14
Day's Change
-0.01 (-0.16%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.22
Day's Low
6.02
Volume
(Below Average)
Volume:
378,009

10-day average volume:
451,967
378,009

ADTRAN, Inc. to Release Third Quarter Earnings on October 30, 2019

2:00 pm ET September 27, 2019 (BusinessWire) Print

ADTRAN, Inc. (NASDAQ: ADTN) announced today that the Company will release its financial results for the third quarter 2019 after market close on Wednesday, October 30, 2019. The Company will conduct a conference call on Thursday, October 31, 2019 to discuss the results for the quarter.

What: ADTRAN Earnings Call When: 9:30 a.m. Central Time on Thursday, October 31, 2019 Where: www.adtran.com/investor

ADTRAN will webcast this conference. To listen, simply visit ADTRAN's Investor Relations site at www.adtran.com/investor approximately 10 minutes prior to the start of the call and click on the conference call link provided. An online replay of the conference call, as well as the transcript of the call, will be available on the Investor Relations site shortly following the call and will remain available for at least 12 months.

At ADTRAN, Inc., we believe amazing things happen when people connect. From the cloud edge to the subscriber edge, we help communications service providers around the world manage and scale services that connect people, places and things to advance human progress. Whether rural or urban, domestic or international, telco or cable, enterprise or residential--ADTRAN solutions optimize existing technology infrastructures and create new, multi-gigabit platforms that leverage cloud economics, data analytics, machine learning and open ecosystems--the future of global networking. Find more at ADTRAN, LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190927005396/en/

SOURCE: ADTRAN, Inc.

Investor Services/Assistance:
Rhonda Lambert/256-963-7054
investor@adtran.com

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.